These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25529738)

  • 1. 5Z-7-Oxozeaenol covalently binds to MAP2K7 at Cys218 in an unprecedented manner.
    Sogabe Y; Matsumoto T; Hashimoto T; Kirii Y; Sawa M; Kinoshita T
    Bioorg Med Chem Lett; 2015 Feb; 25(3):593-6. PubMed ID: 25529738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved gatekeeper methionine regulates the binding and access of kinase inhibitors to ATP sites of MAP2K1, 4, and 7: Clues for developing selective inhibitors.
    Yumura S; Kitagawa D; Moritsugu K; Nakayama A; Shinada T; Sawa M; Kinoshita T
    Bioorg Med Chem Lett; 2024 Nov; 112():129914. PubMed ID: 39111728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A crucial role of Cys218 in configuring an unprecedented auto-inhibition form of MAP2K7.
    Sogabe Y; Hashimoto T; Matsumoto T; Kirii Y; Sawa M; Kinoshita T
    Biochem Biophys Res Commun; 2016 Apr; 473(2):476-81. PubMed ID: 26987717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
    Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
    ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
    Fakhouri L; El-Elimat T; Hurst DP; Reggio PH; Pearce CJ; Oberlies NH; Croatt MP
    Bioorg Med Chem; 2015 Nov; 23(21):6993-9. PubMed ID: 26481152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution structure discloses the potential for allosteric regulation of mitogen-activated protein kinase kinase 7.
    Kinoshita T; Hashimoto T; Sogabe Y; Fukada H; Matsumoto T; Sawa M
    Biochem Biophys Res Commun; 2017 Nov; 493(1):313-317. PubMed ID: 28890347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia.
    Chen TJ; Du W; Junco JJ; Bridges CS; Shen Y; Puppi M; Rabin KR; Lacorazza HD
    Oncotarget; 2021 Aug; 12(18):1787-1801. PubMed ID: 34504651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy.
    Khan S; Bjij I; Betz RM; Soliman ME
    Future Med Chem; 2018 May; 10(9):1003-1015. PubMed ID: 29629569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
    Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
    J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for producing selective MAP2K7 inhibitors.
    Murakawa Y; Valter S; Barr H; London N; Kinoshita T
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127546. PubMed ID: 32931911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a cysteine residue in the active site of ERK and the MAPKK family.
    Ohori M; Kinoshita T; Yoshimura S; Warizaya M; Nakajima H; Miyake H
    Biochem Biophys Res Commun; 2007 Feb; 353(3):633-7. PubMed ID: 17194451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of 2-cyanoacrylamide derivatives tethered to imidazopyridine as TAK1 inhibitors.
    Kang SJ; Lee JW; Song J; Park J; Choi J; Suh KH; Min KH
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1928-1936. PubMed ID: 33086897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
    Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
    Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells.
    Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T
    Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling and crystal structure of ERK2-hypothemycin complexes.
    Rastelli G; Rosenfeld R; Reid R; Santi DV
    J Struct Biol; 2008 Oct; 164(1):18-23. PubMed ID: 18571434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (5Z)-7-Oxozeaenol: A novel and potent resorcylic acid lactone kinase inhibitor with a cis-enone Michael acceptor.
    Ellestad GA
    Chirality; 2019 Feb; 31(2):110-117. PubMed ID: 30565749
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
    Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
    Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
    Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
    J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
    Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
    Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
    Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J
    Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.